OCGN Archived Articles
Ocugen (NASDAQ:OCGN): Pioneering Biotech Advancing Novel Therapies for Blindness Diseases
Published on March 14, 2025
Ocugen Inc. (OCGN): A Pioneering Biotech Transforming the Landscape of Genetic Eye Diseases
Published on November 30, 2024
Ocugen, Inc. (NASDAQ:OCGN): Pioneering Gene Therapies to Restore Vision and Hope
Published on September 24, 2024